Search - tctmd.com

Displaying 381 - 400 of 877

Sort: Relevancy | Date

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Amulet I: Device Evolution, Patient Selection, and Tips and Tricks

Presenter: Reda Ibrahim

June 13, 2019

Presentation TVT 2019

Watchman I: Device Evolution, Patient Selection, and Tips and Tricks

Presenter: Saibal Kar

June 13, 2019

News Daily News

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Caitlin E. Cox

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Coronary Access Issues) – A Case-Based Discussion

Presenter: Stanley Chetcuti

June 13, 2019

Presentation TVT 2019

Latest Clinical Data in Bicuspid Disease

Presenter: John Forrest

June 13, 2019

Presentation TVT 2019

Imaging Implantation Tips and Tricks

Presenter: Nicolo Piazza

June 13, 2019

Presentation TVT 2019

Advanced Design Features and Future Vision

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

The Evolut Low-Risk Randomized Trial

Presenter: Steven Yakubov

June 13, 2019

Presentation TVT 2019

Updates From the CoreValve and EVOLUT R Aortic VIV Registries

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot Study

Presenter: Gilbert Tang

June 13, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Conference News HRS 2019

HRS Urges Members to Get Aboard the Digital Health Train

Todd Neale

May 10, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Daily News

EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially

Michael O'Riordan

April 22, 2019

Presentation Fellows 2019

The Evolution in PCI Pharmacology Over the Past 25 Years

Presenter: Deepak L. Bhatt

April 12, 2019

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

Caitlin E. Cox

April 12, 2019

Advertisement

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Amulet I: Device Evolution, Patient Selection, and Tips and Tricks

Watchman I: Device Evolution, Patient Selection, and Tips and Tricks

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Coronary Access Issues) – A Case-Based Discussion

Latest Clinical Data in Bicuspid Disease

Imaging Implantation Tips and Tricks

Advanced Design Features and Future Vision

The Evolut Low-Risk Randomized Trial

Updates From the CoreValve and EVOLUT R Aortic VIV Registries

Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot Study

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

HRS Urges Members to Get Aboard the Digital Health Train

FDA Approves Lotus Edge, Ushering Third Device Into US Market

EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially

The Evolution in PCI Pharmacology Over the Past 25 Years

Latest Observational Data Support TAVR Durability Through 7 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content